Casdin Capital

Casdin Capital as of March 31, 2018

Portfolio Holdings for Casdin Capital

Casdin Capital holds 31 positions in its portfolio as reported in the March 2018 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Loxo Oncology 7.3 $42M 360k 115.37
Foundation Medicine 7.2 $41M 520k 78.75
Sage Therapeutics (SAGE) 7.1 $40M 250k 161.07
Blueprint Medicines (BPMC) 5.6 $32M 348k 91.70
Spark Therapeutics 5.4 $31M 463k 66.59
Agios Pharmaceuticals (AGIO) 5.2 $30M 365k 81.78
Alnylam Pharmaceuticals (ALNY) 5.2 $30M 250k 119.10
Global Blood Therapeutics In 5.1 $29M 600k 48.30
Myokardia 4.8 $27M 560k 48.80
Sangamo Biosciences (SGMO) 4.7 $27M 1.4M 19.00
Fate Therapeutics (FATE) 4.5 $25M 2.6M 9.76
Bluebird Bio (BLUE) 4.3 $25M 145k 170.75
Codexis (CDXS) 3.9 $22M 2.0M 11.00
Voyager Therapeutics (VYGR) 3.8 $21M 1.1M 18.79
GenMark Diagnostics 3.7 $21M 3.9M 5.44
Illumina (ILMN) 3.0 $17M 72k 236.42
Evolent Health (EVH) 2.8 $16M 1.1M 14.25
Jounce Therapeutics 2.5 $14M 635k 22.35
Audentes Therapeutics 2.4 $14M 450k 30.05
Beigene (BGNE) 2.1 $12M 70k 168.00
iShares NASDAQ Biotechnology Index (IBB) 1.8 $10M 95k 106.74
Clovis Oncology 1.6 $9.4M 178k 52.80
Crispr Therapeutics (CRSP) 1.1 $6.2M 135k 45.71
Cytomx Therapeutics (CTMX) 1.0 $5.9M 208k 28.45
Editas Medicine (EDIT) 0.8 $4.4M 133k 33.15
Neogen Corporation (NEOG) 0.8 $4.4M 65k 66.98
OraSure Technologies (OSUR) 0.7 $4.1M 240k 16.89
Celgene Corporation 0.6 $3.6M 40k 89.20
Zai Lab (ZLAB) 0.5 $2.9M 135k 21.35
Adverum Biotechnologies 0.3 $1.7M 300k 5.80
Homology Medicines 0.2 $1.1M 60k 18.70